Daniel Kroiss

Daniel Kroiss

Daniel Kroiss is Senior Vice President, Business Development and Chief Scientific Officer of MicroPort CRM.

He has held various positions within the Research and Development field from 1982 to 2011. He became Chief Scientific Officer from 2011 to 2018, Vice President, Business Development from 2016 to 2018 and Vice President Research and Development until 2020

Over the years, Daniel Kroiss managed, within ELA Medical and Sorin CRM, the design and development of particularly innovative implantable devices, combining performance and miniaturization, with the goal of providing patients, suffering from cardiac rhythm diseases, advanced therapeutic solutions. Daniel Kroiss has contributed to the achievement of world firsts in the field: development of the first dual chamber defibrillator in 1995, and the smallest defibrillator in the world in 2005.

In 2009, at the head of the Department "Integrated Circuits Development", he led multi-functional teams of electronic development, implantable devices qualification and Sorin’s center specialized in radio frequency communication, a technology pillar of CRM’s tele-cardiology system.

Daniel Kroiss is, since the beginning of his career, an active member of both European and International standardization committees and provided his knowledge in the drafting of standards governing active implantable medical devices.

Until April 2018, in his role as Chief Scientific Officer, Daniel Kroiss was also in charge of research and innovation and lead, as such, the Advanced Research, Clinical Research and Intellectual Property departments.

Daniel Kroiss graduated from INSA Lyon, France, in electrical engineering.